VENUNGOPAL P, BALAKRISHNAN K, SRIRAM DK, GEORGE M. INCLISIRAN (LEQVIO): A FIRST-IN-CLASS SMALL INTERFERING RNA THERAPEUTIC DRUG APPROVED BY FDA FOR TREATING PRIMARY HYPERCHOLESTEROLEMIA OR DYSLIPIDEMIA. Asian J Pharm Clin Res [Internet]. 2022 Dec. 7 [cited 2024 Nov. 26];15(12):42-6. Available from: https://journals.innovareacademics.in/index.php/ajpcr/article/view/46054